Female Health ROE 2006-2020 | VERU

Current and historical return on equity (ROE) values for Female Health (VERU) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Female Health ROE for the three months ending March 31, 2020 was -31.14%.
Female Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $-0.01B $0.03B -31.25%
2019-12-31 $-0.01B $0.03B -39.69%
2019-09-30 $-0.01B $0.03B -34.78%
2019-06-30 $-0.02B $0.04B -50.37%
2019-03-31 $-0.02B $0.03B -64.71%
2018-12-31 $-0.02B $0.04B -61.54%
2018-09-30 $-0.02B $0.03B -63.58%
2018-06-30 $-0.02B $0.04B -49.41%
2018-03-31 $-0.01B $0.04B -30.27%
2017-12-31 $-0.01B $0.05B -24.49%
2017-09-30 $-0.01B $0.05B -17.65%
2017-06-30 $-0.01B $0.05B -12.63%
2017-03-31 $-0.00B $0.05B -9.14%
2016-12-31 $-0.00B $0.05B -5.06%
2016-09-30 $0.00B $0.03B 0.00%
2016-06-30 $0.00B $0.04B 8.63%
2016-03-31 $0.00B $0.04B 8.89%
2015-12-31 $0.01B $0.04B 15.27%
2015-09-30 $0.01B $0.03B 16.00%
2015-06-30 $0.00B $0.03B 10.00%
2015-03-31 $0.00B $0.03B 10.26%
2014-12-31 $0.00B $0.03B 3.51%
2014-09-30 $0.00B $0.03B 3.51%
2014-06-30 $0.01B $0.03B 30.77%
2014-03-31 $0.01B $0.03B 31.30%
2013-12-31 $0.01B $0.03B 42.48%
2013-09-30 $0.02B $0.03B 55.56%
2013-06-30 $0.02B $0.03B 63.37%
2013-03-31 $0.02B $0.03B 76.60%
2012-12-31 $0.02B $0.02B 80.00%
2012-09-30 $0.02B $0.02B 82.05%
2012-06-30 $0.01B $0.02B 73.24%
2012-03-31 $0.01B $0.02B 62.50%
2011-12-31 $0.01B $0.02B 52.46%
2011-09-30 $0.01B $0.02B 33.90%
2011-06-30 $0.01B $0.01B 41.38%
2011-03-31 $0.01B $0.01B 42.11%
2010-12-31 $0.01B $0.02B 58.18%
2010-09-30 $0.01B $0.02B 53.85%
2010-06-30 $0.00B $0.01B 24.49%
2010-03-31 $0.00B $0.01B 33.33%
2009-12-31 $0.00B $0.01B 34.78%
2009-09-30 $0.01B $0.01B 65.12%
2009-06-30 $0.01B $0.01B 70.00%
2009-03-31 $0.01B $0.01B 73.68%
2008-12-31 $0.01B $0.01B 64.86%
2008-09-30 $0.01B $0.01B 55.56%
2008-06-30 $0.00B $0.01B 48.48%
2008-03-31 $0.00B $0.01B 40.00%
2007-12-31 $0.00B $0.01B 29.63%
2007-09-30 $0.00B $0.01B 16.67%
2007-06-30 $0.00B $0.01B 0.00%
2007-03-31 $0.00B $0.01B 0.00%
2006-12-31 $0.00B $0.01B 0.00%
2006-09-30 $0.00B $0.01B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B 0.00%
2005-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.227B $0.032B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $161.726B 28.05
Medtronic (MDT) Ireland $122.997B 19.98
Stryker (SYK) United States $67.540B 21.92
Boston Scientific (BSX) United States $49.131B 23.10
Baxter (BAX) United States $43.670B 26.66
Lonza Group Ag (LZAGY) Switzerland $39.461B 0.00
Terumo (TRUMY) Japan $28.983B 37.05
EssilorLuxottica Societe Anonyme (ESLOY) France $28.175B 0.00
ResMed (RMD) United States $27.776B 43.84
Zimmer Biomet Holdings (ZBH) United States $24.636B 15.50
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.688B 0.00
Bio-Rad Laboratories (BIO) United States $13.385B 60.93
Insulet (PODD) United States $12.255B 1214.13
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.397B 73.84
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.534B 13.48
Hill-Rom Holdings (HRC) United States $7.306B 20.60
GN STORE NORD (GNNDY) Denmark $6.972B 36.02
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.669B 0.00
Haemonetics (HAE) United States $4.505B 27.06
Neogen (NEOG) United States $4.090B 69.29
ICU Medical (ICUI) United States $3.840B 28.01
GW Pharmaceuticals (GWPH) United Kingdom $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.684B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.679B 0.00
Envista Holdings (NVST) United States $3.358B 0.00
NuVasive (NUVA) United States $2.852B 22.91
National Vision Holdings (EYE) United States $2.450B 42.39
TG Therapeutics (TGTX) United States $2.146B 0.00
AtriCure (ATRC) United States $1.801B 0.00
Aurora Cannabis (ACB) Canada $1.407B 0.00
MacroGenics (MGNX) United States $1.372B 0.00
Aphria (APHA) Canada $1.228B 0.00
Cardiovascular Systems (CSII) United States $1.113B 0.00
NanoString Technologies (NSTG) United States $1.107B 0.00
Cerus (CERS) United States $1.082B 0.00
Phibro Animal Health (PAHC) United States $1.063B 21.18
Meridian Bioscience (VIVO) United States $0.998B 37.56
PetIQ (PETQ) United States $0.989B 28.56
InMode (INMD) Israel $0.905B 19.14
Vapotherm (VAPO) United States $0.873B 0.00
Zynex (ZYXI) United States $0.826B 82.90
Omeros (OMER) United States $0.802B 0.00
Quanterix (QTRX) United States $0.775B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.744B 123.85
OraSure Technologies (OSUR) United States $0.722B 145.38
Eagle Pharmaceuticals (EGRX) United States $0.657B 47.04
VAREX IMAGING (VREX) United States $0.592B 14.71
Surmodics (SRDX) United States $0.588B 70.89
Lantheus Holdings (LNTH) United States $0.569B 11.44
LeMaitre Vascular (LMAT) United States $0.533B 30.34
Owens & Minor (OMI) United States $0.480B 12.70
BioLife Solutions (BLFS) United States $0.425B 148.64
Viemed Healthcare (VMD) United States $0.373B 33.10
Repro-Med Systems (KRMD) United States $0.362B 299.33
Cytosorbents (CTSO) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.323B 23.44
HEXO (HEXO) $0.318B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.297B 0.00
Organigram Holdings (OGI) Canada $0.274B 0.00
InfuSystems Holdings (INFU) United States $0.232B 128.22
Chimerix (CMRX) United States $0.192B 0.00
Bovie Medical (APYX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.186B 0.00
Evolus (EOLS) United States $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
Fonar (FONR) United States $0.138B 12.21
Rockwell Medical (RMTI) United States $0.135B 0.00
United Health Products (UEEC) United States $0.130B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
MTech Acquisition (KERN) United States $0.117B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.076B 0.00
United-Guardian (UG) United States $0.068B 15.76
Capricor Therapeutics (CAPR) United States $0.066B 0.00
Chembio Diagnostics (CEMI) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.052B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.034B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00